Report Store | Pharma intelligence
  • My Account
    • 0Shopping Cart
  • $0.00
  • Disease analysis
    • Anemias
    • Bacterial infections
    • Bleeding disorders
    • Brain Cancer
    • Breast and gynecological cancer
    • Cardiovascular and Metabolic
    • Central Nervous System
    • Cerebrovascular diseases
    • Dermatology
    • Diabetes and diabetic complications
    • Gastroenterology
    • Gastrointestinal cancer
    • Head and Neck Cancer
    • Hypertension
    • Immunology and Inflammation
    • Infectious Diseases
    • Ischemic heart disease
    • Leukemia
    • Lung Cancer
    • Lymphoma
    • Oncology overview
    • Market Spotlight
    • Mens Health
    • Neurology
    • Oncology
    • Ophthalmology
    • Other Hematological Cancers
    • Other metabolic diseases
    • Other Solid Cancers
    • Pain
    • Psychiatry
    • Respiratory
    • Rheumatology
    • Skin cancer
    • Thrombosis
    • Urological cancer
    • Vaccines
    • Viral infections
    • Women’s Health
  • Strategy analysis
    • Bleeding disorders
    • Breast and gynecological cancer
    • Cardiovascular and Metabolic
    • Central Nervous System
    • Commercial Strategy
    • Dealmaking and R&D
    • Head and Neck Cancer
    • Hot Topics
    • Infectious Diseases
    • KOL Insight
    • Leukemia
    • Lung Cancer
    • Manufacturing
    • Market Access
    • Neurology
    • Oncology
    • Outsourcing
    • Pricing & Reimbursement
    • R&D
    • Regulatory & Therapeutic Area
    • Trends
    • Urological cancer
  • Company analysis
    • Big Pharma
    • Emerging Pharma
    • Hot Topics
    • Japan Pharma
    • M&A Analysis
    • Mid Pharma
  • Drug analysis
    • A
    • B-C
    • D-F
    • G-L
    • M-O
    • P-R
    • S-T
    • U-Z
  • MedTech analysis
    • Allergy
    • Autoimmune / Immunology
    • Cardiovascular
    • Dermatology
    • Endocrine
    • ENT / Dental
    • Gastroenterology
    • Hearing
    • Hematology
    • Infectious Diseases
    • Metabolic
    • Neurology
    • Obstetrics / Gynecology
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Osteoporosis
    • Psychiatry
    • Renal
    • Respiratory
    • Rheumatology
    • Urology
  • Opinion & analysis
    • Business Development
    • Business Management
    • Clinical Trials
    • Digital Health
    • Cybersecurity
    • Compliance & Risk
    • Digital patient management
    • Digital policy & regulation
    • Finance & Pricing
    • Healthcare Innovation
    • ICT and Health
    • Leadership
    • Legislation Regulation & Policy
    • Market Access
    • Market Intelligence
    • Medical
    • Pharmaceutical Device
    • Pharmaceutical Research
    • Strategy & Innovation
    • Tech companies & Data
    • Tech & Pharma
  • Blogs
  • Search
  • Menu
You are here: Home > Disease analysis > Infectious Diseases > Viral infections

Viral infections


show blocks helper
loader
  • Sort by Default
    • Default
    • Custom
    • Name
    • Price
    • Date
    • Popularity (sales)
    • Average rating
    • Relevance
    • Random
    • Product ID
  • Display 15 Products per page
    • 15 Products per page
    • 30 Products per page
    • 45 Products per page
  • Disease Analysis: COVID-19 Prevention

    Read More

    COVID-19 is an infectious disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus that emerged in late 2019 in Wuhan, China. As of 27 November 2020, there have been 60,704,174 confirmed cases of COVID-19, and 1,416,292 confirmed deaths globally.

    December 1, 2020
    Find out more
  • Disease Analysis: COVID-19 Treatment

    Read More

    COVID-19 is an infectious disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus that emerged in late 2019 in Wuhan, China. As of 24 November 2020, there have been 58,712,326 confirmed cases of COVID-19, and 1,388,528 confirmed deaths globally. SARS-CoV-2 belongs to the coronavirus family, which collectively cause respiratory and intestinal disease in humans and animals, with other prominent members of the family including Middle East respiratory syndrome (MERS) virus and severe acute respiratory syndrome (SARS) virus. SARS-CoV-2 is believed to have originated from a horseshoe bat coronavirus, which either spread to humans directly or jumped via an intermediate host (possibly a pangolin), which may have facilitated transmission to humans

    November 25, 2020
    Find out more
  • Dengue vaccines

    Dengue Vaccines

    Read More

    Dengue fever is an emerging flaviviral infection transmitted mainly by Aedes aegypti and Aedes albopictus mosquitoes.

    November 13, 2020
    Find out more
  • Market Spotlight: Zika virus

    $1,318.00

    This Market Spotlight report covers the Zika virus market, comprising key pipeline therapies, clinical trials, probability of success, epidemiology, and licensing and acquisition deals.

    November 12, 2020
    Find out more
  • Market Spotlight: Hepatitis B

    $1,318.00

    This Market Spotlight report covers the Hepatitis B market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming and regulatory events, probability of success,patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.

    November 5, 2020
    Find out more
  • Market Spotlight: Norovirus

    $1,318.00

    This Market Spotlight report covers the Norovirus market, comprising key pipeline drugs, clinical trials, recent events, and an epidemiological overview.

    October 22, 2020
    Find out more
  • Hepatitis C

    Disease Analysis: Hepatitis C

    Read More

    Hepatitis C (HCV) product revenues will decline significantly during the 2020–29 forecast period, with sales in the US, Japan, and five major European markets (France, Germany, Italy, Spain, and the UK) falling from $3.2bn to $1.3bn, at a compound annual growth rate of -9.4%. With no new pipeline agents expected to gain approval, and fierce pricing competition between established players ruling out the annual price increases typically observed in the lucrative US market, the erosion in market value will be primarily driven by a stepwise decline in patient numbers as the influx of newly diagnosed patients fails to offset the high number of patients exiting the treatment algorithm due to cure.

    October 15, 2020
    Find out more
  • Hepatitis B disease forecast and market analysis to 2035

    Read More

    Hepatitis B is a viral infection caused by the hepatitis B virus (HBV) that attacks the liver and can cause both acute and chronic disease. HBV is transmitted perinatally from mother to child and through contact with infected blood or other bodily fluids. Despite a safe and effective vaccine being available, HBV continues to represent a major health problem and can lead to acute liver failure, acute hepatitis, chronic hepatitis, liver cirrhosis, liver cancer, liver transplantation, and death.

    October 25, 2018
    Find out more
  • Datamonitor Healthcare Seasonal Influenza Vaccines KOL Interviews

    $599.00

    Datamonitor Healthcare interviewed two infectious disease experts, one based in the US and one in France, to gauge their views on the seasonal influenza vaccines market, its outlook over the next five years and any key events that are likely to take place, including the impact of novel quadrivalent inactivated influenza vaccines and other incremental advances

    April 18, 2017
    Find out more
Page 1 of 1
  • Home
  • Terms and Conditions
  • Refund policy
  • Privacy Policy
  • Cookie Policy
  • Contact Us
  • About Us
  • Discounts
  • Market Spotlight – Reports
  • twitter
  • linkedin
  • Sitemap
Datamonitor Healthcare is part of Pharma intelligence Datamonitor Healthcare is a trading division of Datamonitor Limited, a company registered in England and Wales with company number 2306113 whose registered office is 5 Howick Place, London, SW1P 1WG. VAT GB365462636. Datamonitor Limited is part of Informa PLC.

Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
  • Informa PLC
  • ABOUT US
  • INVESTOR RELATIONS
  • TALENT
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726
informa
Call Back
We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.
By continuing to use the website, you consent to our use of cookies.
OkRead more
Scroll to top